Josepmaria Argemí

机构：University of Pittsburgh, Instituto de Salud Carlos III, Instituto de Salud Pública de Navarra, Navarre Institute of Health Research, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University of Pittsburgh Medical Center, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra · ORCID：0000-0003-1696-7753

发表论文 193 篇 · 总被引 3356 次 · h-index 31

代表论文

• Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma (2026 · Cell Reports Medicine · 被引 2)
• Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma (2026 · Molecular Therapy Oncology · 被引 1)
• Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy (2026 · OncoImmunology · 被引 1)
• Single cell multiomic landscape reveals gene programs driving lipid droplet heterogeneity in hepatic steatosis (2026 · Scientific Reports · 被引 1)
• Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis (2026 · International Journal of Molecular Sciences · 被引 1)
• NASIR-HCC JITC 2026 (2026 · ImmPort)